RNA editing oligonucleotide selected for AATD treatment
Drug Discovery World
DECEMBER 12, 2023
KRRO-110 is designed to co-opt an endogenous enzyme Adenosine Deaminase Acting on RNA (ADAR) to repair a pathogenic single nucleotide variant (SNV) on RNA and restore production of normal A1AT.
Let's personalize your content